Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herling

Showing results (371-380 of 481) with videos related to

Pageof 49
Sort By:
Science Advances|July 10, 2024
Thermodynamic profiles for cotranslational trigger factor substrate recognitionTherese W Herling, Anaïs M E Cassaignau, Anne S Wentink, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2015
Force generation by the growth of amyloid aggregatesTherese W Herling, Gonzalo A Garcia, Thomas C T Michaels, et al.
The Journal of Experimental Medicine|November 21, 2024
JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLLShifa Khaja Saleem, Sarah Decker, Sandra Kissel, et al.
The Journal of Organic Chemistry|October 31, 2018
Enantioselective Vanadium-Catalyzed Oxidative Coupling: Development and Mechanistic InsightsHoung Kang, Madison R Herling, Kyle A Niederer, et al.
The Journal of Biological Chemistry|May 11, 2001
Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048T H van Dijk, F H van der Sluijs, C H Wiegman, et al.
Prenatal Diagnosis|January 22, 2021
The prognosis of common arterial trunk from a fetal perspective: A prenatal cohort study and systematic literature reviewAmber E L van Nisselrooij, Lotta Herling, Sally-Ann Clur, et al.
Journal of Medicinal Chemistry|September 30, 2005
Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetesThomas Klabunde, K Ulrich Wendt, Dieter Kadereit, et al.
Clinical Lymphoma & Myeloma|December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experienceFarhad Ravandi, Susan O'Brien, Dan Jones, et al.
Journal of Medicinal Chemistry|June 8, 2018
Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose FormulationsAndreas Evers, Martin Bossart, Stefania Pfeiffer-Marek, et al.
Leukemia|May 5, 2015
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLLE Vasyutina, J M Boucas, J Bloehdorn, et al.
Pageof 49

Showing results (371-380 of 481) with videos related to

Sort By:
Pageof 49
Science Advances|July 10, 2024
Thermodynamic profiles for cotranslational trigger factor substrate recognitionTherese W Herling, Anaïs M E Cassaignau, Anne S Wentink, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2015
Force generation by the growth of amyloid aggregatesTherese W Herling, Gonzalo A Garcia, Thomas C T Michaels, et al.
The Journal of Experimental Medicine|November 21, 2024
JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLLShifa Khaja Saleem, Sarah Decker, Sandra Kissel, et al.
The Journal of Organic Chemistry|October 31, 2018
Enantioselective Vanadium-Catalyzed Oxidative Coupling: Development and Mechanistic InsightsHoung Kang, Madison R Herling, Kyle A Niederer, et al.
The Journal of Biological Chemistry|May 11, 2001
Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048T H van Dijk, F H van der Sluijs, C H Wiegman, et al.
Prenatal Diagnosis|January 22, 2021
The prognosis of common arterial trunk from a fetal perspective: A prenatal cohort study and systematic literature reviewAmber E L van Nisselrooij, Lotta Herling, Sally-Ann Clur, et al.
Journal of Medicinal Chemistry|September 30, 2005
Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetesThomas Klabunde, K Ulrich Wendt, Dieter Kadereit, et al.
Clinical Lymphoma & Myeloma|December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experienceFarhad Ravandi, Susan O'Brien, Dan Jones, et al.
Journal of Medicinal Chemistry|June 8, 2018
Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose FormulationsAndreas Evers, Martin Bossart, Stefania Pfeiffer-Marek, et al.
Leukemia|May 5, 2015
The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLLE Vasyutina, J M Boucas, J Bloehdorn, et al.
Pageof 49